BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38172354)

  • 21. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
    Liu K; Xue B; Bai G; Zhang W
    Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LEM domain containing 1 (LEMD1) transcriptionally activated by SRY-related high-mobility-group box 4 (SOX4) accelerates the progression of colon cancer by upregulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway.
    Li D; Wang D; Liu H; Jiang X
    Bioengineered; 2022 Apr; 13(4):8087-8100. PubMed ID: 35294319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silencing of COL1A2, COL6A3, and THBS2 inhibits gastric cancer cell proliferation, migration, and invasion while promoting apoptosis through the PI3k-Akt signaling pathway.
    Ao R; Guan L; Wang Y; Wang JN
    J Cell Biochem; 2018 Jun; 119(6):4420-4434. PubMed ID: 29143985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway.
    Hu W; Hu Y; Pei Y; Li R; Xu F; Chi X; Mi J; Bergquist J; Lu L; Zhang L; Yang C
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1.
    Wang W; Guo Z; Yu H; Fan L
    J Cell Biochem; 2019 Apr; 120(4):5435-5443. PubMed ID: 30302807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
    Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
    J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop.
    Yang H; Wen L; Wen M; Liu T; Zhao L; Wu B; Yun Y; Liu W; Wang H; Wang Y; Wen N
    Anticancer Drugs; 2018 Mar; 29(3):216-226. PubMed ID: 29360662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-25-3p targets PTEN to regulate the migration, invasion, and apoptosis of esophageal cancer cells via the PI3K/AKT pathway.
    Zhang L; Tong Z; Sun Z; Zhu G; Shen E; Huang Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32985648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
    He S; Liao B; Deng Y; Su C; Tuo J; Liu J; Yao S; Xu L
    BMC Cancer; 2017 Oct; 17(1):673. PubMed ID: 28978307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway.
    Lu D; Sun L; Li Z; Mu Z
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of lncRNA HULC knockdown on rat secreting pituitary adenoma GH3 cells.
    Rui QH; Ma JB; Liao YF; Dai JH; Cai ZY
    Braz J Med Biol Res; 2019; 52(4):e7728. PubMed ID: 30994730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RacGAP1 promotes the malignant progression of cervical cancer by regulating AP-1 via miR-192 and p-JNK.
    Zhang T; Wang C; Wang K; Liang Y; Liu T; Feng L; Yang X
    Cell Death Dis; 2022 Jul; 13(7):604. PubMed ID: 35831303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
    Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
    Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of FOXM1 suppresses cell growth and metastasis in human laryngeal cancer via the AKT signaling pathway.
    Yan J; Hou J; Yan Y; Ren XY; Luo HN; Wang ZG; Zheng GX
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6786-6793. PubMed ID: 32633370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-520d-5p functions as a tumor-suppressor gene in cervical cancer through targeting PTK2.
    Zhang L; Liu F; Fu Y; Chen X; Zhang D
    Life Sci; 2020 Aug; 254():117558. PubMed ID: 32198053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.